“…Three of the more traditional choices at this point are interferon therapy, 47 retinoid therapy, 48 and methotrexate therapy. 51,52 All three have been shown to enhance a response to phototherapy and are discussed later in systemic therapies commonly used in managing MF in skin of color. Interferon-alfa is dosed from 3 to 18 M units subcutaneously three times per week, methotrexate is typically given in weekly doses ranging from 15 to 30 mg per week, and the retinoid bexarotene is used at doses of 150 to 450 mg per day in conjunction with phototherapy to achieve remission.…”